Repligen Corporation (NASDAQ:RGEN) Files An 8-K Submission of Matters to a Vote of Security Holders

0

Repligen Corporation (NASDAQ:RGEN) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders.

The Repligen Corporation 2018 Stock Option and Incentive Plan was approved. The results of the vote were as follows:

FOR AGAINST ABSTAIN BROKER NON-VOTES

NUMBER

31,190,620 1,016,057 28,544 3,435,247

PERCENTAGE OF VOTED

96.75 % 3.15 % 0.08 %


About Repligen Corporation (NASDAQ:RGEN)

Repligen Corporation is a bioprocessing company. The Company is focused on the development, production and commercialization of products used in the process of manufacturing biologic drugs (bioprocessing). The Company is a manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing to separate and purify monoclonal antibodies, a type of biologic drug. The Company also supplies several growth factor products, Alternating Tangential Flow (ATF) System products and cell filtration products used to increase cell culture productivity during the bioproduction process. The Company has developed a series of OPUS chromatography columns for use in clinical-scale manufacturing. The Company manufactures and sells Protein A and growth factors to life sciences companies under long-term supply agreements and sells its chromatography columns, as well as media and quality test kits.